[1]
2026. Review of new biological drugs and JAK inhibitors approved for children and adolescents with moderate to severe atopic dermatitis: the situation in Uruguay. Archives of Pediatrics of Uruguay. 97, 1 (Apr. 2026), e801. DOI:https://doi.org/10.31134/AP.97.1.20.